Risk factors for prosthesis failure in pulmonary valve replacement

Area of Science:

• Cardiovascular Surgery
• Biomaterials Science
• Pediatric Cardiology

Background:

• Pulmonary valve replacement (PVR) is crucial after initial right ventricular outflow tract reconstruction.
• Bioprosthetic valve failure (PVF) necessitates reoperation, making risk factor identification vital.
• Understanding PVF predictors aids clinicians in selecting optimal initial PVR strategies.

Purpose of the Study:

• To identify risk factors associated with pulmonary valve bioprosthetic valve failure (PVF).
• To evaluate the long-term outcomes of different bioprosthetic valve types used for PVR.
• To inform clinical decision-making for initial PVR procedures.

Main Methods:

• Retrospective analysis of 169 patients undergoing first PVR for repaired Tetralogy of Fallot or pulmonary stenosis.
• Data collection included patient demographics, diagnosis, PVR indication, age at PVR, valve type, and time to PVF.
• Actuarial freedom from PVF was assessed using survival analysis; risk factors were analyzed via univariate and multivariate methods.

Main Results:

• Freedom from PVF at 10 years was 72% across all valve types.
• Younger age at PVR, male gender, and pulmonary stenosis diagnosis were identified as univariate risk factors for PVF.
• Multivariate analysis revealed younger age, Tetralogy of Fallot anatomy, and homograft use as risk factors for early PVF (<3 years).

Conclusions:

• Excellent freedom from reoperation for PVR is achievable within 10 years.
• Younger age at PVR is a significant risk factor for both early and late PVF.
• Tetralogy of Fallot and homograft use are associated with increased risk of early PVF.